497 filings
Page 5 of 25
8-K
ATOS
Atossa Therapeutics Inc
13 Aug 21
Atossa Therapeutics Announces Second Quarter 2021 Financial Results - Provides Corporate Update and Information about Upcoming Stockholder Meeting
9:30am
DEF 14A
ATOS
Atossa Therapeutics Inc
Definitive proxy
9 Aug 21
4:01pm
PRE 14A
ATOS
Atossa Therapeutics Inc
Preliminary proxy
29 Jul 21
4:01pm
4
ATOS
Atossa Therapeutics Inc
7 Jul 21
ATOSSA THERAPEUTICS / GREGORY L WEAVER ownership change
4:29pm
8-K
ATOS
Atossa Therapeutics Inc
18 May 21
Departure of Directors or Certain Officers
4:39pm
4
Stephen J Galli
18 May 21
ATOSSA THERAPEUTICS / Stephen J Galli ownership change
4:18pm
4
ATOS
Atossa Therapeutics Inc
18 May 21
ATOSSA THERAPEUTICS / STEVEN C QUAY ownership change
4:18pm
4
Guse Kyle
18 May 21
ATOSSA THERAPEUTICS / Kyle Guse ownership change
4:18pm
4
Chen Shu-Chih
18 May 21
ATOSSA THERAPEUTICS / Shu-Chih Chen ownership change
4:18pm
4
ATOS
Atossa Therapeutics Inc
18 May 21
ATOSSA THERAPEUTICS / STEVEN C QUAY ownership change
4:18pm
4
Remmel H. Lawrence
18 May 21
ATOSSA THERAPEUTICS / H. Lawrence Remmel ownership change
4:18pm
4
ATOS
Atossa Therapeutics Inc
18 May 21
ATOSSA THERAPEUTICS / GREGORY L WEAVER ownership change
4:16pm
4
ATOS
Atossa Therapeutics Inc
18 May 21
ATOSSA THERAPEUTICS / Richard I Steinhart ownership change
4:16pm
10-Q
2021 Q1
ATOS
Atossa Therapeutics Inc
Quarterly report
14 May 21
9:47am
8-K
ATOS
Atossa Therapeutics Inc
14 May 21
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
9:15am
DEFA14A
ATOS
Atossa Therapeutics Inc
11 May 21
Additional proxy soliciting materials
4:07pm
EFFECT
ATOS
Atossa Therapeutics Inc
30 Apr 21
Notice of effectiveness
12:15am
CORRESP
ATOS
Atossa Therapeutics Inc
27 Apr 21
Correspondence with SEC
12:00am
UPLOAD
ATOS
Atossa Therapeutics Inc
26 Apr 21
Letter from SEC
12:00am
S-3
ATOS
Atossa Therapeutics Inc
Shelf registration
21 Apr 21
4:27pm